Coinbase Global Inc. (NASDAQ: COIN): Keefe Bruyette downgraded the stock to Underperform from Market Perform and has a $45 target price. The consensus target is $108.23. Tuesday’s close at $87.68 was down almost 11% on the day after posting a wider-than-expected loss.

Eaton Corp. PLC (NYSE: ETN): Oppenheimer maintained an Outperform rating with a $170 target price. The consensus target is $161.65. The shares ended Tuesday trading at $146.41.

Enovix Corp. (NASDAQ: ENVX): Loop Capital began coverage on the battery company with a Buy rating and a $50 target. The consensus target is $23.80. The last trade Tuesday was reported at $14.41, up over 5% for the day on the strong upgrade.

Federal Realty Investment Trust (NYSE: FRT): BofA Securities raised its Neutral rating to Buy and lifted hiked the $110 target price objective to $130. The consensus target is $118.59. The stock closed on Tuesday at $107.41.

Garmin Ltd. (NASDAQ: GRMN): This stock was selected as the Bear of the Day at Zacks, which cited “tough-to-compete against periods” and downbeat guidance. Shares have traded as high as $178.81 in the past year but closed most recently at $95.12, which is down around 30% year to date.

GoodRx Holdings Inc. (NASDAQ: GDRX): Goldman Sachs raised its price target on the Neutral-rated shares to $10 from $9. The consensus target is $9.29. The stock closed on Tuesday at $7.81.

Healthcare Realty Trust Inc. (NYSE: HR): Citigroup resumed coverage with a Neutral rating and a $27 target. This consensus target of $32.79. The shares closed on Tuesday at $25.86, up 2% for the day.

Myovant Sciences Ltd. (NYSE: MYOV): SVB Leerink upgraded the stock to Outperform from Market Perform and boosted the $12 price target to $23. The consensus target is $18.20. The stock was last seen Tuesday at $16.68, up over 6% on the day. Tuesday, the FDA approved Myfembree, the joint venture with Pfizer for endometriosis-associated pain.

Micron Technology Inc. (NASDAQ: MU): Raymond James downgraded the chip giant to Outperform from Strong Buy. It also cut its $72 price target to $65, well below the $77.35 consensus target. Tuesday’s last trade of $59.15 was down close to 4% for the day.

NRG Energy Inc. (NYSE: NRG): Goldman Sachs lowered its target price on the utility giant to $46 from $52 but kept a Buy rating. The consensus target is $44.27. Tuesday’s close was at $38.33.

Nutrien Ltd. (NYSE: NTR): Scotiabank upgraded the shares to Sector Outperform from Sector Perform, but it also trimmed the $118 target price to $110. The consensus target is $111.49. The stock closed over 3% higher on Tuesday at $88.34.

Nvidia Corp. (NASDAQ: NVDA): Baird stuck with a Neutral rating with a $150 price target on the chip giant. The consensus is target is up at $233.84 for now. The shares closed Tuesday at $170.86, down almost 4% on the day, as the semiconductor sector has been weak across the board.

PubMatic Inc. (NASDAQ: PUBM): Oppenheimer lowered its $30 price objective to $28 while maintaining an Outperform rating. The consensus target is $27.65. After posting outstanding results for the quarter, its $21.98 closing share price on Tuesday bounced up 24% on the day.

Restaurant Brands International Inc. (NYSE: QSR): Argus upgraded the stock to Buy from Hold and has a $67 target price. The consensus target is $84.17. The shares closed on Tuesday at $59.25.